Tag: Cancer: Rectal

USPSTF concludes with moderate certainty that CRC screening has moderate net benefit for those aged 45 to 49 years

Risk for EO-CRC increased with each serving per day during adulthood and during adolescence at ages 13 to 18 years

Sequencing results from universal panel changed cancer treatment for roughly one in 10 colorectal cancer patients

Multitarget stool DNA test, fecal immunochemical test, or guaiac-based fecal occult blood test preferred over colonoscopy

Adding machine learning-based image analysis allows noninvasive differentiation of benign and premalignant polyps

Review of meta-analyses of prospective observational studies reveals lower risk with higher intakes of dietary fiber, dietary calcium, yogurt

Screening rates improved in patients due for testing at a community health center predominantly serving people of color

Adding smoke exposure improves the current risk stratification for colorectal neoplasia surveillance strategies

Patients self-ordering FIT tests for colorectal cancer screening through an electronic reminder more likely to complete a kit

Risk for CRC, mortality increased with delayed receipt of colonoscopy compared with colonoscopy within one to three months